Please use this identifier to cite or link to this item: https://doi.org/10.1126/scisignal.aam6790
Title: Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease
Authors: Chen Z.-C. 
Zhang W.
Chua L.-L. 
Chai C. 
Li R.
Lin L.
Cao Z.
Angeles D.C. 
Stanton L.W. 
Peng J.-H.
Zhou Z.-D. 
Lim K.-L. 
Zeng L. 
Tan E.-K. 
Issue Date: 2017
Publisher: American Association for the Advancement of Science
Citation: Chen Z.-C., Zhang W., Chua L.-L., Chai C., Li R., Lin L., Cao Z., Angeles D.C., Stanton L.W., Peng J.-H., Zhou Z.-D., Lim K.-L., Zeng L., Tan E.-K. (2017). Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease. Science Signaling 10 (488) : 6790. ScholarBank@NUS Repository. https://doi.org/10.1126/scisignal.aam6790
Abstract: Mutations in LRRK2, which encodes leucine-rich repeat kinase 2, are the most common genetic cause of familial and sporadic Parkinson's disease (PD), a degenerative disease of the central nervous systemthat causes impaired motor function and, in advanced stages, dementia. Dementia is a common symptom of another neurodegenerative disease, Alzheimer's disease, and research suggests that there may be pathophysiological and genetic links between the two diseases. Aggregates of b amyloid [a protein produced through cleavage of amyloid precursor protein (APP)] are seen in both diseases and inPD patients carrying G2019S-mutant LRRK2.Using patient-derived cells, brain tissue, and PD model mice, we found that LRRK2 interacted with and phosphorylated APP at Thr668 within its intracellular domain (AICD). Phosphorylation of APP at Thr668 promoted AICD transcriptional activity and correlated with increased nuclear abundance of AICD and decreased abundance of a dopaminergic neuron marker in cultures and brain tissue. The AICD regulates the transcription of genes involved in cytoskeletal dynamics and apoptosis. Overexpression of AICD, but not a phosphodeficient mutant (AICDT668A), increased the loss of dopaminergic neurons in older mice expressing LRRK2G2019S. Moreover, the amount of Thr668-phosphorylated APP was substantially greater in postmortem brain tissue and dopaminergic neurons (generated by reprogramming skin cells) from LRRK2G2019S patients than in those fromhealthy individuals. LRRK2 inhibitors reduced the phosphorylation of APP at Thr668 in the patient-derived dopaminergic neurons and in the midbrains of LRRK2G2019S mice. Thus, APP is a substrate of LRRK2, and its phosphorylation promotes AICD function and neurotoxicity in PD. Copyright � 2017 The Authors, some rights reserved.
Source Title: Science Signaling
URI: http://scholarbank.nus.edu.sg/handle/10635/150089
ISSN: 19450877
DOI: 10.1126/scisignal.aam6790
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

14
checked on Aug 19, 2019

WEB OF SCIENCETM
Citations

8
checked on Dec 31, 2018

Page view(s)

45
checked on Aug 15, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.